83 related articles for article (PubMed ID: 2938403)
1. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes and peripheral B lymphocytes in non insulin dependent diabetic patients.
Barañao RI; Tesone PA; Chasseing NA; Mendelson M; Rumi LS
Acta Physiol Lat Am; 1983; 33(2):111-6. PubMed ID: 6230879
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
Casiglia D; Giardina E; Scarantino G; Triolo G
Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
[TBL] [Abstract][Full Text] [Related]
4. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
5. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in diabetic patients with periodontitis.
Anil S; Remani P; Ankathil R; Vijayakumar T
Ann Dent; 1990; 49(2):3-5, 45. PubMed ID: 2278478
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in pulmonary tuberculosis.
Ashtekar MD; Samuel AM
J Clin Lab Immunol; 1985 Oct; 18(2):91-5. PubMed ID: 3935794
[TBL] [Abstract][Full Text] [Related]
8. Some characteristics of neutrophils from diabetic patients and their relation to the levels of circulating immune complexes.
Barañao RI; Rumi LS; Tesone PA; Foglia VG
Acta Diabetol Lat; 1988; 25(1):13-23. PubMed ID: 3407375
[TBL] [Abstract][Full Text] [Related]
9. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus.
Triolo G; Giardina E; Seddio G; Terrizzi C
Boll Ist Sieroter Milan; 1987; 66(2):116-9. PubMed ID: 3311077
[TBL] [Abstract][Full Text] [Related]
10. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
11. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
[TBL] [Abstract][Full Text] [Related]
12. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
Triolo G; Giardina E; Bompiani GD
J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies.
Delespesse G; Gausset P; Sarfati M; Dubi-Rucquoy M; Debisschop MJ; van Haelst L
Clin Exp Immunol; 1980 Apr; 40(1):96-102. PubMed ID: 6993080
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.
Abrass CK
Clin Exp Immunol; 1984 Jul; 57(1):17-24. PubMed ID: 6378460
[TBL] [Abstract][Full Text] [Related]
15. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
Fairchild RS; Kyner JL; Abdou NI
J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
[TBL] [Abstract][Full Text] [Related]
16. The variations of the serum IgD and of the circulant immune complexes in diabetic patients.
Cheţa D; Cojocaru M; Mogoş T; Iosif C; Cheţa N; Trifan E; Alexandrescu R; Halmagy I; Enache M
Rom J Intern Med; 1992; 30(1):57-62. PubMed ID: 1496260
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease].
Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M
Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
19. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of circulating immune complexes in leprosy.
Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
